Prevention of apoptosis by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-10A cell line: Correlation with increased transforming growth factor α production

Cancer Research

Volumn 61, Issue 8, 2001, Pages 3314-3320

  Davis, John W ^a   Lauer, Fredine T ^a   Burdick, Andrew D ^a   Hudson, Laurie G ^a   Burchiel, Scott W ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 5 (2 BENZOTHIAZOLYL)THIOMETHYL 4 HYDROXY 3 METHOXYBENZYLIDENECYANOACETAMIDE; APOPTOSIS INHIBITOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BREAST EPITHELIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; BENZOTHIAZOLES; BREAST; CELL COUNT; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN; TRANSFORMING GROWTH FACTOR ALPHA; TYRPHOSTINS;

EID: 0035870285     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Recent advances in the molecular genetics of hereditary breast and ovarian cancer
2. The genetics of breast cancer susceptibility
3. Treatment of breast cancer
4. Hereditary breast cancer
5. The Seveso studies on early and long-term effects of dioxin exposure: A review
6. Analysis of breast milk to assess exposure to chlorinated contaminants in Kazakstan: High levels of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) in agricultural villages of southern Kazakstan
7. Polycyclic aromatic hydrocarbons in human fat and liver
8. Environmental organochlorine exposure as a potential etiologic factor in breast cancer
9. Organochlorine pesticide content of breast adipose tissue from women with breast cancer and control subjects
10. Cancer incidence in a population accidentally exposed to 2, 3, 7, 8-tetrachloro-dibenzo-para-dioxin
11. Plasma organochlorine levels and the risk of breast cancer
12. Breast cancer risk and environmental exposures
13. Genetic alterations in breast cancer
14. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis
15. Benzo[α]pyrene- and TCDD-induced alterations in tyrosine phosphorylation and insulin-like growth factor signaling pathways in the MCF-10A human mammary epithelial cell line
16. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits growth factor withdrawal-induced apoptosis in the human mammary epithelial cell line, MCF-10A
17. Mechanisms of apoptosis avoidance in cancer
18. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal
19. Mechanisms and consequences of activation of protein kinase B/Akt
20. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines
21. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
22. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
23. Regulation of cell death protease caspase-9 by phosphorylation
24. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
25. NF-κB is a target of AKT in anti-apoptotic PDGF signaling
26. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms
27. The Ras/phosphatidylinositol 3-kinase and Ras/ERK pathways function as independent survival modules each of which inhibits a distinct apoptotic signaling pathway in sympathetic neurons
28. Growth inhibitory and antimitogenic activity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) in T47D human breast cancer cells
29. Effects of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) on insulin-induced responses in MCF-7 human breast cancer cells
30. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10
31. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells
32. Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure
33. Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR
34. Competitive PCR for quantitation of mRNA
35. RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin and hydrocortisone
36. Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate
37. Tyrosine kinase inhibition: An approach to drug development
38. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells
39. Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation
40. Serum predominantly activates MAPK and akt kinases in EGFR- and ErbB2-over-expressing cells, respectively
41. Dioxin induces transforming growth factor-α in human keratinocytes
42. Apoptosis in tumor biology and therapy
43. Inhibition of apoptosis during 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver
44. Prenatal TCDD and predisposition to mammary cancer in the rat
45. A Competitive binding assay for 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin and related ligands of the Ah receptor
46. Ah receptor signaling pathways
47. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-α and -β2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control
48. Transforming growth factor α and mouse models of human breast cancer
49. Cell cycle basis for the onset and progression of c-Myc-induced, TGFα-enhanced mouse mammary gland carcinogenesis
50. Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-α genes on in vitro transformation of human mammary epithelial cells
51. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II Correlations with proliferation and angiogenesis
52. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: Involvement of MEK upstream of Bad phosphorylation
53. An analysis of Mekl signaling in cell proliferation and transformation
54. Targets for dioxin: Genes for plasminogen activator inhibitor-2 and interleukin-1 β